GentiBio, Inc., is an early stage biotherapeutics company co-founded by pioneers in Treg biology and synthetic immunology to develop engineered regulatory T cells (EngTregs) programmed to treat autoimmune, alloimmune, autoinflammatory and allergic diseases. GentiBio's proprietary autologous and allogeneic EngTregs platform integrates key complimentary technologies needed to successfully restore immune tolerance and overcome major limitations in existing regulatory T-cell therapeutics. GentiBio is at the forefront of leveraging a unique therapeutic modality that can be used to address the fundamental cause of many diseases that result from overshooting and/or malfunctioning of the immune system.

Biotechnology

Education

GentiBio

GentiBio's headquarters in Boston, MA, United States

Tom Crevier

Tom Wickham

Alexa Perdikis

Jaii Fredregill

Rachel Yost

Marko Repic

Hatem Heikal

Adan Jaramillo

Margaret Readio

Alberto del Rio Espinola

Jennifer Hu

John Wesner

Nishat Shaikh

Christopher L. Moore

Tiffany Chen

Tim Guo (Tingxi)

Hatem H.

Abby Meiners

Emily Doll

Brian Christin

Andy Walker

Victoria Devault

Brian Oliver

Martina Sassone-Corsi

Gene Uenishi

Karen Thudium Mueller

David Tucker

Maggie Gose

Payam Zarin

Tim Guo

Dalia Gaddis

Carlos Frias

Kevin Hawkins

Ruth Berry

Maegan Hoover

Sarah Albertson

Shivali Verma

Alaina Burgess

Michael Gillespie

Stanford Peng

Roy Amariglio

Carl L. Gordon

Michal Silverberg

Amy Jennings

Gideon Gross

Andrew M. Scharenberg

Jane Buckner

Hadas Weinstein-Marom

Nandita Shangari

Andy Tran

Abhiram Rao

David Rawlings

Erez Chimovitz

Adam Cotton

Description

People (15)